Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Featured

CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
Blog
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
08/07/2024
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together...
08/07/2024
Journal of Clinical Pathways
Farrukh Awan, MD
Videos
Chronic Lymphocytic Leukemia Treatment Updates
07/31/2024
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some...
07/31/2024
Journal of Clinical Pathways
Laura Bray
Videos
Advocacy to Reduce the Impact of Drug Shortages on Cancer Care
07/23/2024
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her...
07/23/2024
Journal of Clinical Pathways
Sandip Patel, MD
Videos
Recent Advancements in the Non–Small Cell Lung Cancer Treatment Landscape
07/22/2024
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the...
07/22/2024
Journal of Clinical Pathways
Steve Kalloger, MSc
Videos
Trends in Therapeutic Utilization Among Patients With CLL: Results From the Lymphoma Coalition’s 2022 Global Patient Survey Presented at ASCO 2024
07/18/2024
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses...
07/18/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Show Me the Medical Evidence
07/15/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health...
07/15/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
Stephen Colvill, MBA
Conference Coverage
How Collaboration Among Health Care Stakeholders Can Help Mitigate Drug Shortages
07/08/2024
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses...
07/08/2024
Journal of Clinical Pathways
Conference Coverage
The Association Between High Deductible Health Plans and Cancer Survival
07/02/2024
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented...
07/02/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
What Does Quality Mean in Health Care?
07/01/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health...
07/01/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
News
Impact of Care Delays on Health Care Resource Utilization in Patients With Early-Stage Lung Cancer
06/26/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
06/26/2024
Journal of Clinical Pathways
Paul Fu, MD
Interview
How Technology Can Improve Health Care Team Communication
06/17/2024
Paul Fu Jr, MD, MPH, City of Hope National Medical Center
Paul Fu Jr, MD, MPH, discusses the benefits of using technology to assist health team communication practices.
Paul Fu Jr, MD, MPH, discusses the benefits of using technology to assist health team communication practices.
Paul Fu Jr, MD, MPH, discusses...
06/17/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

From the Journal

From the Field
Shifting the Paradigm: The Impact of AI at the Point of Care in Cancer Treatment
06/03/2024
Stephen Speicher, MD, MS
Will Shapiro
Taylor Dias-Foundas
This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.
This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.
This report explores the...
06/03/2024
Journal of Clinical Pathways
Research Reports
PSA Outcomes and Clinical Surveillance Among Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With a Next-Generation Androgen Receptor Inhibitor in Urology Practices With or Without In-Office Dispensing
06/03/2024
Sabree C. Burbage, PharmD
Dexter Waters, MSPH
Carmine Rossi, PhD
Frederic Kinkead, MA
Erik Muser, PharmD
Lorie Ellis, PhD
Patrick Lefebvre, MA
Dominic Pilon, MA
This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...
This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...
This study describes...
06/03/2024
Journal of Clinical Pathways
From the Field
Bringing Value to Health Care
06/03/2024
Andrew Pecora, MD
Lili Brillstein, MPH
Maher Albitar, MD
Nasim Asfar, MD, MBA, SFHM
Joel Brill, MD
Jeffrey R. Curtis, MD, MS, MPH
Andrew von Eschenbach, MD
Deborah Goss, MD
Andre Goy, MD
Max Holfert
Andrew Ip, MD, MS
Allen Karp
Mark Lutes
Steven Madreperla, MD, PhD
Patrick A. Roth, MD
Miruna Sasu
Robert Shelley
Robin L. Smith, MD, MBA
Nina Tandon, PhD, MBA
Dan Varga, MD
Richard Winters, MD
This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.
This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.
This paper provides insights and...
06/03/2024
Journal of Clinical Pathways
Research Reports
Patient-Reported Outcomes in Hematopoietic Stem Cell Transplant Recipients: Design, Implementation, and Pilot Results
02/21/2024
Christi Ann Hayes, MD
Aricca D. Van Citters, MS
Wenyan Zhao, PhD
Kate L. Caldon
Charlotte M. Coughenour
Tor D. Tosteson, PhD
Anna N. A. Tosteson, PhD
Kenneth R. Meehan, MD
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann...
02/21/2024
Journal of Clinical Pathways
From the Field
Comprehensive Genomic Testing: Tissue Stewardship and Best Practices
02/12/2024
Rebecca A. Previs, MD, MS
Maureen E. Cooper, BS
Kyle C. Strickland, MD
Heidi Ko, DO
Michelle F. Green, PhD
Faezeh Koohestani, PhD
Stephanie Hastings, PhD
Zachary Wallen, PhD
Sarabjot Pabla, PhD
Jeffrey M. Conroy, BS
Mary Nesline, MS
Shengle Zhang, MD
Durga Prasad Dash, PhD
Brian Caveney, MD, JD, MPH
Marcia Eisenberg, PhD
Eric Severson, MD, PhD
Shakti H. Ramkissoon, MD, PhD
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al...
02/12/2024
Journal of Clinical Pathways
Perspectives
The Key Factors Driving Low Participation in the Enhancing Oncology Model
02/12/2024
Theresa Dreyer, MPH
Theresa Dreyer, MPH, investigates the challenges leading to a substantial decline in participation among academic oncology practices within the Enhancing Oncology Model.
Theresa Dreyer, MPH, investigates the challenges leading to a substantial decline in participation among academic oncology practices within the Enhancing Oncology Model.
Theresa Dreyer, MPH,...
02/12/2024
Journal of Clinical Pathways
Research Reports
Enhancing Multidisciplinary Team Processes in Lung Cancer Care: A Self-Assessment Toolkit and Best Practices
02/09/2024
Poka Cui
Peter Blanshard
María Teresa Campos-Partera
Adrien Moucquot
S. Hassan R. Naqvi
David Dellamonica
Heather Moses
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues...
02/09/2024
Journal of Clinical Pathways
Research Reports
The Impact of Social Determinants of Health Beyond Race on Survival in Metastatic Prostate Cancer: A Systematic Literature Review
12/14/2023
Stephen J. Freedland, MD
Imtiaz A. Samjoo, MSc, PhD
Emily Rosta, MSc
Austin Lansing, MSc
Alexandra Hall, MPH
Manvir Rai, BSc
Alexander Niyazov, PharmD, MPH
Jonathan L. Nazari, PharmD
Bhakti Arondekar, PhD, MBA
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
A systematic literature review...
12/14/2023
Journal of Clinical Pathways
Research Reports
Clinical and Economic Impact of Implementing HealthPathways at a Musculoskeletal Radiology Department
12/13/2023
Simon R. Davies, MBBCh, MD
Kathleen Lyons, MBBCh
Kausik Mukherjee, MBBS
Ramakrishna Kishore, MBBS
Khurram Hashmi, MBBCh
Maria Dyban, LLM
Anna Kuczynska, MBBCh
Simon R. Davies, MBBCh, and colleagues investigate the impact of HealthPathways on management and primary care clinicians in a musculoskeletal radiology department.
Simon R. Davies, MBBCh, and colleagues investigate the impact of HealthPathways on management and primary care clinicians in a musculoskeletal radiology department.
Simon R. Davies, MBBCh, and...
12/13/2023
Journal of Clinical Pathways
Research Reports
Off-Label Use of Precision Oncology Therapeutics in Advanced Solid Cancers Following Identification of Associated Variants via Multicancer Next-Generation Sequencing Panel: A Real-World Evidence Pilot Study
09/19/2023
Julie Wiedower, PhDc
Nicole Zhang, MPH
Rebecca Nagy, MS
Kathryn Lang, MD
Jayati Saha, PhD, MPH
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and...
09/19/2023
Journal of Clinical Pathways

Advertisement

Guideline Updates

Deborah Stephens, DO, University of Utah
Videos
Overview of the Updated NCCN Guidelines on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
05/17/2023
Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, and member of the NCCN Guidelines Panel for the Management of CLL, provides an overview of the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN...
Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, and member of the NCCN Guidelines Panel for the Management of CLL, provides an overview of the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN...
Deborah Stephens, DO, Huntsman...
05/17/2023
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Clinical Practice Guidelines for Multiple Myeloma
01/11/2023

Yvette C. Terrie

Yvette C. Terrie
The NCCN recently published updated recommendations for the management of MM regarding newly diagnosed transplant-eligible and transplant-ineligible patients with MM, maintenance, and previously treated MM, and principles of management of...
The NCCN recently published updated recommendations for the management of MM regarding newly diagnosed transplant-eligible and transplant-ineligible patients with MM, maintenance, and previously treated MM, and principles of management of...
The NCCN recently published...
01/11/2023
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Clinical Practice Guidelines in Thyroid Carcinoma
09/08/2022

Yvette C Terrie

Yvette C Terrie
The National Comprehensive Cancer Network recently published updated recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, along with surgical management of differentiated thyroid carcinoma.
The National Comprehensive Cancer Network recently published updated recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, along with surgical management of differentiated thyroid carcinoma.
The National Comprehensive...
09/08/2022
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Therapy Guidelines in Bladder Cancer
08/26/2022

Yvette C Terrie

Yvette C Terrie
NCCN Guidelines Panel for Bladder Cancer presented data evaluating new treatment options in bladder cancer, as well as relevant updates to the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.
NCCN Guidelines Panel for Bladder Cancer presented data evaluating new treatment options in bladder cancer, as well as relevant updates to the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.
NCCN Guidelines Panel for...
08/26/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Videos

Farrukh Awan, MD
Videos
Chronic Lymphocytic Leukemia Treatment Updates
07/31/2024
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some...
07/31/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Why People Should Care About How Health Care Works (Part 1)
07/29/2024
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part...
07/29/2024
Cancer Care Business Exchange
Ivy Altomare, MD
Videos
Characteristics of Clinical Trials in Community Oncology Practices Across the US
07/23/2024
Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.
Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.
Ivy Altomare, MD, provides an...
07/23/2024
Journal of Clinical Pathways
Laura Bray
Videos
Advocacy to Reduce the Impact of Drug Shortages on Cancer Care
07/23/2024
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her...
07/23/2024
Journal of Clinical Pathways
Sandip Patel, MD
Videos
Recent Advancements in the Non–Small Cell Lung Cancer Treatment Landscape
07/22/2024
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the...
07/22/2024
Journal of Clinical Pathways
Steve Kalloger, MSc
Videos
Trends in Therapeutic Utilization Among Patients With CLL: Results From the Lymphoma Coalition’s 2022 Global Patient Survey Presented at ASCO 2024
07/18/2024
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses...
07/18/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Show Me the Medical Evidence
07/15/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health...
07/15/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
What Does Quality Mean in Health Care?
07/01/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health...
07/01/2024
Cancer Care Business Exchange
Moritz Furstenau, MD
Conference Coverage
Efficacy and ctDNA Analysis of MRD-Guided Acalabrutinib, Venetoclax, and Obinutuzumab for Patients With R/R CLL
06/26/2024

Featuring Moritz Furstenau, MD

Featuring Moritz Furstenau, MD ...
At the 65th ASH Annual Meeting, Moritz Furstenau, MD, presented a follow-up analysis of the CLL2-Baag trial on the efficacy and ctDNA analysis of acalabrutinib, venetoclax, and obinutuzumab combination therapy after optional debulking with...
At the 65th ASH Annual Meeting, Moritz Furstenau, MD, presented a follow-up analysis of the CLL2-Baag trial on the efficacy and ctDNA analysis of acalabrutinib, venetoclax, and obinutuzumab combination therapy after optional debulking with...
At the 65th ASH Annual Meeting,...
06/26/2024
Oncology
Tony Mok, MD
Conference Coverage
Adagrasib Improved Survival and Response Among Patients With KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
06/17/2024
Tony Mok, MD
According to results from the phase 3 KRYSTAL-12 trial, adagrasib improved survival and response compared to docetaxel among patients with previously treated KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer.
According to results from the phase 3 KRYSTAL-12 trial, adagrasib improved survival and response compared to docetaxel among patients with previously treated KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer.
According to results from the...
06/17/2024
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Features

From the Field
Shifting the Paradigm: The Impact of AI at the Point of Care in Cancer Treatment
06/03/2024
Stephen Speicher, MD, MS
Will Shapiro
Taylor Dias-Foundas
This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.
This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.
This report explores the...
06/03/2024
Journal of Clinical Pathways
Research Reports
PSA Outcomes and Clinical Surveillance Among Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With a Next-Generation Androgen Receptor Inhibitor in Urology Practices With or Without In-Office Dispensing
06/03/2024
Sabree C. Burbage, PharmD
Dexter Waters, MSPH
Carmine Rossi, PhD
Frederic Kinkead, MA
Erik Muser, PharmD
Lorie Ellis, PhD
Patrick Lefebvre, MA
Dominic Pilon, MA
This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...
This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...
This study describes...
06/03/2024
Journal of Clinical Pathways
From the Field
Bringing Value to Health Care
06/03/2024
Andrew Pecora, MD
Lili Brillstein, MPH
Maher Albitar, MD
Nasim Asfar, MD, MBA, SFHM
Joel Brill, MD
Jeffrey R. Curtis, MD, MS, MPH
Andrew von Eschenbach, MD
Deborah Goss, MD
Andre Goy, MD
Max Holfert
Andrew Ip, MD, MS
Allen Karp
Mark Lutes
Steven Madreperla, MD, PhD
Patrick A. Roth, MD
Miruna Sasu
Robert Shelley
Robin L. Smith, MD, MBA
Nina Tandon, PhD, MBA
Dan Varga, MD
Richard Winters, MD
This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.
This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.
This paper provides insights and...
06/03/2024
Journal of Clinical Pathways
Research Reports
Patient-Reported Outcomes in Hematopoietic Stem Cell Transplant Recipients: Design, Implementation, and Pilot Results
02/21/2024
Christi Ann Hayes, MD
Aricca D. Van Citters, MS
Wenyan Zhao, PhD
Kate L. Caldon
Charlotte M. Coughenour
Tor D. Tosteson, PhD
Anna N. A. Tosteson, PhD
Kenneth R. Meehan, MD
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann...
02/21/2024
Journal of Clinical Pathways
From the Field
Comprehensive Genomic Testing: Tissue Stewardship and Best Practices
02/12/2024
Rebecca A. Previs, MD, MS
Maureen E. Cooper, BS
Kyle C. Strickland, MD
Heidi Ko, DO
Michelle F. Green, PhD
Faezeh Koohestani, PhD
Stephanie Hastings, PhD
Zachary Wallen, PhD
Sarabjot Pabla, PhD
Jeffrey M. Conroy, BS
Mary Nesline, MS
Shengle Zhang, MD
Durga Prasad Dash, PhD
Brian Caveney, MD, JD, MPH
Marcia Eisenberg, PhD
Eric Severson, MD, PhD
Shakti H. Ramkissoon, MD, PhD
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al...
02/12/2024
Journal of Clinical Pathways

Columns

Transformative Employer Trends
Pathways, Affordability, and Utilization for Precision Therapies
06/03/2024
F. Randy Vogenberg, PhD, FASHP
Jeffrey Warren, MPA
Alasdair Roe, ACII
This column discusses how there is a stakeholder disconnect in precision medicine, leaving employers and other commercial plans or administrators seeking solutions as they face emerging risks from precision therapies.
This column discusses how there is a stakeholder disconnect in precision medicine, leaving employers and other commercial plans or administrators seeking solutions as they face emerging risks from precision therapies.
This column discusses how there...
06/03/2024
Journal of Clinical Pathways
MAI Mindset
December 2023 Pathways Impact Study Part 3: Importance of “on-Pathway” Status for Treatment Selection
06/03/2024
Lee Blansett, MBA
This entry of our MAI Mindset column summarizes the third part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
This entry of our MAI Mindset column summarizes the third part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
This entry of our MAI Mindset...
06/03/2024
Journal of Clinical Pathways
Editor's Page
Perspectives on Fixing a Disjointed Health Care System
06/03/2024
Winston Wong, PharmD, Editor-in-Chief
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including perspectives from stakeholders on the disjointed health care system in the US and how clinical pathways can help fix it.
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including perspectives from stakeholders on the disjointed health care system in the US and how clinical pathways can help fix it.
Editor-in-Chief Winston Wong,...
06/03/2024
Journal of Clinical Pathways
Transformative Employer Trends
Shared Decision-Making on Health Care Risks
03/27/2024
F. Randy Vogenberg, PhD, FASHP
This column explores the purpose behind managing risk and determining how conflict around care cost management can occur, including through the use of pathways.
This column explores the purpose behind managing risk and determining how conflict around care cost management can occur, including through the use of pathways.
This column explores the purpose...
03/27/2024
Journal of Clinical Pathways
MAI Mindset
December 2023 Pathways Impact Study Part 2: Impact of Pathway Programs on Treatment Selection
03/27/2024
Lee Blansett, MBA
This entry of our MAI Mindset column summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
This entry of our MAI Mindset column summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
This entry of our MAI Mindset...
03/27/2024
Journal of Clinical Pathways

Departments

Conference Highlights
Highlights From the 65th ASH Annual Meeting & Exposition
02/09/2024
The American Society of Hematology Annual Meeting & Exposition was held in San Diego, California, December 9-12, 2023. Read our selection of online news coverage of the conference that features the discoveries, emerging therapies, and...
The American Society of Hematology Annual Meeting & Exposition was held in San Diego, California, December 9-12, 2023. Read our selection of online news coverage of the conference that features the discoveries, emerging therapies, and...
The American Society of...
02/09/2024
Journal of Clinical Pathways
Conference Highlights
Key Highlights From CPC+CBEx 2023
12/14/2023
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress +...
12/14/2023
Journal of Clinical Pathways
Corrigendum
Corrigendum: The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences
12/14/2023
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
In the June 2022 issue of the...
12/14/2023
Journal of Clinical Pathways
Clinical Pathways Forum
Beyond Adherence: Clinical Pathways at Roswell Park
12/13/2023
Mishellene McKinney, MHA, RN, OCN—Column Editor
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
For the August 2023 Clinical...
12/13/2023
Journal of Clinical Pathways
Clinical Pathways Forum
Precision Medicine Testing in Oncology: Benefits of and Barriers to Adoption
09/19/2023
Mishellene McKinney, MHA, RN, OCN—Column Editor
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical...
09/19/2023
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Recent Stories

CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
Blog
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
08/07/2024
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together...
08/07/2024
Journal of Clinical Pathways
Farrukh Awan, MD
Videos
Chronic Lymphocytic Leukemia Treatment Updates
07/31/2024
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some...
07/31/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Why People Should Care About How Health Care Works (Part 1)
07/29/2024
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part...
07/29/2024
Cancer Care Business Exchange
News
Examining Treatment Delay Trends in Patients With Lung Cancer
07/24/2024
A study in Missouri uncovers a disturbing trend of increasing delays in lung cancer treatment initiation, surpassing national guidelines and prompting a call for further investigation into potential causes.
A study in Missouri uncovers a disturbing trend of increasing delays in lung cancer treatment initiation, surpassing national guidelines and prompting a call for further investigation into potential causes.
A study in Missouri uncovers a...
07/24/2024
Journal of Clinical Pathways
Steven Chen Headshot
Commentary
The Role of Bioimpedance Spectroscopy in Standardizing Lymphedema Clinical Pathways
07/24/2024
Lymphedema is a frequently overlooked complication affecting cancer survivors, occurring when normal lymphatic drainage is disrupted, leading to the buildup of protein-rich lymph fluid in the interstitial space. If left untreated, it can...
Lymphedema is a frequently overlooked complication affecting cancer survivors, occurring when normal lymphatic drainage is disrupted, leading to the buildup of protein-rich lymph fluid in the interstitial space. If left untreated, it can...
Lymphedema is a frequently...
07/24/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement